Name | LABORATORIYA EMANSI, ZAO |
|---|
INN | 7705388160 |
|---|
KPP | 770501001 |
|---|
OGRN | 1027700317710 |
|---|
OKPO | 54817826 |
|---|
FFSM | 23864-H |
|---|
Address | 119049, G.moskva, per. 1-y Lyusinovskiy, d. D.3B, of. 1 |
|---|
Phone | 237-73-82 Contact details |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 72.19 | Core activity | Research and experimental development on natural sciences and engineering Other | | 32.50 | Additional activity | Dental Laboratories |
Registration date | 15.10.2002 |
|---|
Registering department | Upravlenie Ministerstva Rossiyskoy Federatsii po nalogam i sboram po g.Moskve |
|---|
|
LABORATORIYA EMANSI, ZAO (Moscow; INN 7705388160) was registered on 15 Oct 2002. The company's authorized capital as of July 1, 2012 was 40000 rub. Type of ownership of LABORATORIYA EMANSI, ZAO - Closed joint-stock companies. Form of ownership of LABORATORIYA EMANSI, ZAO - Private property. Principal activities of LABORATORIYA EMANSI, ZAO: research and experimental development on natural sciences and engineering other (72.19), dental laboratories (32.50). |
Economic indicators2023
Net profit (RAS) of LABORATORIYA EMANSI, ZAO grew over 2023 by 4.69% to 151.06 million RUB from 144.29 million RUB over 2022, the company informed. Revenue increased in the accounting period by 8.23% to 503.69 million RUB from 465.37 million RUB over 2022; cost of goods sold decreased by 6.31% to 156.86 million RUB from 167.42 million RUB; sales profit went up by 3.33% to 145.55 million RUB from 140.86 million RUB. 2022
Net profit (RAS) of LABORATORIYA EMANSI, ZAO grew over 2022 by 38.84% to 144.29 million RUB from 103.92 million RUB over 2021, the company informed. Revenue increased in the accounting period by 3.75% to 465.37 million RUB from 448.54 million RUB over 2021; cost of goods sold decreased by 9.69% to 167.42 million RUB from 185.38 million RUB; sales profit went up by 36.82% to 140.86 million RUB from 102.95 million RUB. 2021
Net profit (RAS) of LABORATORIYA EMANSI, ZAO dropped in 2021 by 1.50% to 103.92 million RUB from 105.51 million RUB over the same period in 2020, the company informed. Revenue increased in the accounting period by 16.46% to 448.54 million RUB from 385.14 million RUB over 2020; cost of goods sold grew by 28.94% to 185.38 million RUB from 143.77 million RUB; sales profit fell by 3.58% to 102.95 million RUB from 106.77 million RUB. 2020
Net profit (RAS) of LABORATORIYA EMANSI, ZAO grew over 2020 2.74 times to 105.51 million RUB from 38.49 million RUB over 2019, the company informed. Revenue increased in the accounting period by 41.93% to 385.14 million RUB from 271.36 million RUB over 2019; cost of goods sold decreased by 2.29% to 143.77 million RUB from 147.14 million RUB; sales profit went up 2.81 times to 106.77 million RUB from 38.03 million RUB. 2018
Net profit (RAS) of LABORATORIYA EMANSI, ZAO dropped in 2018 by 47.17% to 39.00 million RUB from 73.82 million RUB over the same period in 2017, the company informed. Revenue decreased in the accounting period by 10.20% to 251.62 million RUB from 280.21 million RUB in 2017; cost of goods sold grew by 2.06% to 155.35 million RUB from 152.22 million RUB; sales profit fell by 46.91% to 39.17 million RUB from 73.78 million RUB. 2017
Net profit (RAS) of LABORATORIYA EMANSI, ZAO grew over 2017 2.17 times to 73.82 million RUB from 34.07 million RUB over 2016, the company informed. Revenue increased in the accounting period by 42.50% to 280.21 million RUB from 196.64 million RUB over 2016; cost of goods sold grew by 33.36% to 152.22 million RUB from 114.14 million RUB; sales profit went up 1.76 times to 73.78 million RUB from 41.97 million RUB. 2016
Net profit (RAS) of LABORATORIYA EMANSI, ZAO grew over 2016 3.09 times to 34.07 million RUB from 11.02 million RUB over 2015, the company informed. Revenue increased in the accounting period by 45.44% to 196.64 million RUB from 135.21 million RUB over 2015; cost of goods sold grew by 26.13% to 114.14 million RUB from 90.49 million RUB; sales profit went up 3.01 times to 41.97 million RUB from 13.94 million RUB. 2014
Revenue decreased in the accounting period by 7.57% to 96.10 million RUB from 103.97 million RUB in 2013; cost of goods sold decreased by 8.04% to 62.87 million RUB from 68.37 million RUB. 2012
Net profit (RAS) of Laboratoriya EHMANSI, ZAO dropped in 2012 by 18.74% to 21.16 million RUB from 26.04 million RUB over the same period in 2011, the company informed. Revenue decreased in the accounting period by 8.72% to 103.00 million RUB from 112.84 million RUB in 2011; cost of goods sold decreased by 24.40% to 76.70 million RUB from 101.46 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|